|
🐜
|
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
76 auth.
A. Lotery,
S. Sivaprasad,
A. O’Connell,
R. Harris,
L. Culliford,
L. Ellis,
A. Cree,
S. Madhusudhan,
F. Behar-Cohen,
U. Chakravarthy,
T. Peto,
C. Rogers,
B. Reeves,
Samir Bellani,
H. Griffiths,
...
S. Thulasidharan,
Catrin Watkins,
Rebecca A. Kaye,
D. Menon,
Qin Neville,
Rebecca Denham,
K. Gillvray,
S. Abugreen,
Natalie Nixon,
Mohammed Alarbi,
F. Ghanchi,
Zeid Madanat,
N. Hawes,
Edward Hughes,
Campbell Keir,
K. Kisza,
C. Bailey,
Phillippa Hazlewood,
Julie Cloake,
G. Menon,
M. Chandran,
A. Raguro,
M. Mohamed,
W. S. Lim,
H. Eleftheriadis,
Stefanos Efraimidis,
M. Mckibbin,
R. Mukherjee,
Joanne Wilson,
P. Lenfestey,
S. Harding,
K. Haigh,
R. Chhabra,
Mania Horani,
Raisa-Marie Platt,
J. Talks,
Devanga Bhatia,
V. Andrews,
S. Downes,
I. Samuel,
D. Buttress,
S. Pagliarini,
Linzi Randle,
Jeanette Allison,
C. Brand,
Maria Edwards,
N. Karia,
Mary Shipman,
Elridge Thompson,
A. Kotagiri,
D. Steel,
S. Dodds,
S. Turner,
Y. Osoba,
S. Criddle,
Yit Yang,
N. Narendran,
Meena Karpoor,
R. Gale,
Archana Airody,
Alison Grice-Holt
|
7 |
2020 |
7
🐜
|
